Black Rock Inc. Soleno Therapeutics Inc Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.16 - $2.48 $824 - $12,786	-5,156 Closed	0 $0
Q2 2022 Aug 12, 2022	SELL	$0.14 - $0.23 $17,522 - $28,787	-125,161 Reduced 96.04%	5,156 $1,000
Q1 2022 May 12, 2022	SELL	$0.22 - $0.47 $1,324 - $2,829	-6,021 Reduced 4.42%	130,317 $29,000
Q4 2021 Feb 10, 2022	BUY	$0.41 - $0.91 $2,691 - $5,974	6,565 Added 5.06%	136,338 $56,000
Q3 2021 Nov 09, 2021	BUY	$0.8 - $1.12 $93,102 - $130,343	116,378 Added 868.82%	129,773 $120,000
Q2 2021 Aug 11, 2021	BUY	$0.97 - $1.32 $12,993 - $17,681	13,395 New	13,395 $16,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $388M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.